Spyre Therapeutics to Participate in Upcoming March Investor Conferences

Rhea-AI Summary

Spyre Therapeutics (NASDAQ: SYRE), a clinical-stage biotechnology company focused on antibody engineering and therapeutic combinations for Inflammatory Bowel Disease (IBD) and other immune-mediated diseases, has announced its participation in two upcoming investor conferences in March 2025.

The company will attend the TD Cowen 45th Annual Healthcare Conference in Boston on March 4, 2025, where management will participate in a fireside chat at 3:10pm ET and hold one-on-one meetings. Additionally, Spyre will be present at the Jefferies Biotech on the Beach Summit in Miami on March 11, 2025, for one-on-one meetings.

Live audio webcasts and replays of the TD Cowen fireside chat will be available on the company's investor events website at https://ir.spyre.com/events-and-presentations.

Positive

• Spyre Therapeutics is actively engaging with investors through participation in prestigious healthcare conferences
• The company is providing accessibility to investors through both in-person meetings and webcasted events
• Spyre is developing potentially best-in-class treatments for inflammatory bowel disease and other immune-mediated conditions

Negative

• The press release doesn't provide specific updates on clinical progress or pipeline developments
• No financial information or business updates were included in the announcement
• The company is still in clinical-stage with no mention of marketed products or revenue generation

News Market Reaction – SYRE

-2.87%

1 alert

-2.87% News Effect

On the day this news was published, SYRE declined 2.87%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

WALTHAM, Mass., Feb. 25, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflammatory Bowel Disease ("IBD") and other immune-mediated diseases, today announced that management will participate in the following upcoming investor conferences:

Event: TD Cowen 45^th Annual Healthcare Conference
Format: Fireside chat and 1x1 meetings
Date/Time: Tuesday, March 4, 2025 at 3:10pm ET
Location: Boston, MA

Event: Jefferies Biotech on the Beach Summit
Format: 1x1 meetings
Date: Tuesday, March 11, 2025
Location: Miami, FL

Live audio webcasts and replays of the TD Cowen fireside event will be available on the Spyre investor events website at https://ir.spyre.com/events-and-presentations.

About Spyre Therapeutics
Spyre Therapeutics is a biotechnology company that aims to create next-generation inflammatory bowel disease (IBD) and other immune-mediated disease products by combining best-in-class antibody engineering, dose optimization, and rational therapeutic combinations. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23. For more information, visit Spyre's website at www.spyre.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/spyre-therapeutics-to-participate-in-upcoming-march-investor-conferences-302383597.html

SOURCE Spyre Therapeutics, Inc.

FAQ

When is Spyre Therapeutics (SYRE) presenting at the TD Cowen Healthcare Conference?

Spyre Therapeutics (SYRE) will present at the TD Cowen 45th Annual Healthcare Conference on Tuesday, March 4, 2025, at 3:10pm ET in Boston, MA. The presentation will be in a fireside chat format, and management will also participate in one-on-one meetings.

Where can investors watch Spyre Therapeutics' (SYRE) March 2025 conference presentations?

Investors can watch live audio webcasts and replays of Spyre Therapeutics' TD Cowen fireside chat on the company's investor events website at https://ir.spyre.com/events-and-presentations.

What investor conferences will Spyre Therapeutics (SYRE) attend in March 2025?

Spyre Therapeutics (SYRE) will attend two investor conferences in March 2025: the TD Cowen 45th Annual Healthcare Conference in Boston on March 4, and the Jefferies Biotech on the Beach Summit in Miami on March 11.

What therapeutic areas does Spyre Therapeutics (SYRE) focus on?

Spyre Therapeutics (SYRE) focuses on Inflammatory Bowel Disease (IBD) and other immune-mediated diseases. The company advances best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for these conditions.

Will Spyre Therapeutics (SYRE) offer one-on-one meetings at the March 2025 conferences?

Yes, Spyre Therapeutics (SYRE) will offer one-on-one meetings at both March 2025 conferences. The company will have 1x1 meetings at the TD Cowen Healthcare Conference on March 4 and at the Jefferies Biotech on the Beach Summit on March 11.